Literature DB >> 12379659

Erbin suppresses the MAP kinase pathway.

Yang Z Huang1, Mengwei Zang, Wen C Xiong, Zhijun Luo, Lin Mei.   

Abstract

We present evidence here that Erbin is a negative regulator of the Ras-Raf-Erk signaling pathway. Expression of Erbin decreases transcription of the AChR epsilon-subunit gene, an event that is mediated by Erk activation. Although it interacts with the ErbB2 C terminus through the PDZ domain, Erbin has no effect on ErbB2 tyrosine phosphorylation or binding to the adaptor proteins Shc and Grb2. In contrast, expression of Erbin greatly impairs activation of Erk, but not Akt, by ligands that activate receptor tyrosine kinases. Moreover, Erbin inhibits the Erk activation by active Ras, while it fails to do so in the presence of active Raf-1. Erbin associates with active Ras, but not inactive Ras nor Raf. Consistently, Erbin interferes with the interaction between Ras and Raf both in vivo and in vitro. Finally, overexpression of Erbin leads to inhibition of NGF-induced neuronal differentiation of PC12 cells, whereas down-regulation of endogenous Erbin by specific siRNA exhibits an opposite effect. Collectively, our study has identified Erbin as a novel suppressor of the Ras signaling by disrupting the Ras-Raf interaction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379659     DOI: 10.1074/jbc.M205413200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Erbin inhibits TGF-β1-induced EMT in renal tubular epithelial cells through an ERK-dependent pathway.

Authors:  Qiaodan Zhou; Rui Zeng; Chuou Xu; Lili Liu; Lin Chen; Pei Kou; Guangchang Pei; Shoujun Bai; Yamin Zhang; Caixia Li; Song Rong; Min Han; Gang Xu
Journal:  J Mol Med (Berl)       Date:  2011-11-25       Impact factor: 4.599

2.  Identification of Erbin interlinking MuSK and ErbB2 and its impact on acetylcholine receptor aggregation at the neuromuscular junction.

Authors:  Luca Simeone; Marion Straubinger; Muhammad Amir Khan; Nancy Nalleweg; Tatiana Cheusova; Said Hashemolhosseini
Journal:  J Neurosci       Date:  2010-05-12       Impact factor: 6.167

3.  Triazine dendrimers as nonviral vectors for in vitro and in vivo RNAi: the effects of peripheral groups and core structure on biological activity.

Authors:  Olivia M Merkel; Meredith A Mintzer; Damiano Librizzi; Olga Samsonova; Tanja Dicke; Brian Sproat; Holger Garn; Peter J Barth; Eric E Simanek; Thomas Kissel
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

Review 4.  The leucine-rich repeat signaling scaffolds Shoc2 and Erbin: cellular mechanism and role in disease.

Authors:  HyeIn Jang; Payton Stevens; Tianyan Gao; Emilia Galperin
Journal:  FEBS J       Date:  2020-07-06       Impact factor: 5.542

5.  14-3-3 gamma associates with muscle specific kinase and regulates synaptic gene transcription at vertebrate neuromuscular synapse.

Authors:  Laure Strochlic; Annie Cartaud; Alexandre Mejat; Régis Grailhe; Laurent Schaeffer; Jean-Pierre Changeux; Jean Cartaud
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-16       Impact factor: 11.205

Review 6.  Nonviral delivery of synthetic siRNAs in vivo.

Authors:  Saghir Akhtar; Ibrahim F Benter
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 7.  Human T-lymphotropic virus proteins and post-translational modification pathways.

Authors:  Carlo Bidoia
Journal:  World J Virol       Date:  2012-08-12

8.  Desmoglein-1/Erbin interaction suppresses ERK activation to support epidermal differentiation.

Authors:  Robert M Harmon; Cory L Simpson; Jodi L Johnson; Jennifer L Koetsier; Adi D Dubash; Nicole A Najor; Ofer Sarig; Eli Sprecher; Kathleen J Green
Journal:  J Clin Invest       Date:  2013-03-25       Impact factor: 14.808

9.  Erbin and the NF2 tumor suppressor Merlin cooperatively regulate cell-type-specific activation of PAK2 by TGF-beta.

Authors:  Mark C Wilkes; Claire E Repellin; Min Hong; Margarita Bracamonte; Sumedha G Penheiter; Jean-Paul Borg; Edward B Leof
Journal:  Dev Cell       Date:  2009-03       Impact factor: 12.270

Review 10.  Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases.

Authors:  Lin Mei; Klaus-Armin Nave
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.